Study details
Enrolling now
Nitrous Oxide as Treatment for Fibromyalgia
University of Chicago
NCT IDNCT05357066ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
50
Study length
about 5.1 years
Ages
18–75
Locations
1 site in IL
About this study
Researchers are testing whether nitrous oxide can help reduce pain in people with fibromyalgia, a chronic condition causing widespread musculoskeletal pain. The trial will compare the effects of nitrous oxide to a placebo (an inactive substance).
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Nitrous oxide gas for inhalation
- 2.Take Placebo
PhasePhase 2
DrugNitrous oxide gas for inhalation
Routeinhaled
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low9%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
anesthetic (Inhaled anesthetic gas; causes analgesia and mild anesthesia)
Drug routes
inhaled
Endpoints
Secondary: Hospital Anxiety and Depression Scale
Body systems
Musculoskeletal